Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/07 → 9/30/08 |
An Open-Label Multi-Centre Study of Lapatinib in Combination with Chemotherapy in Patients with ErB2 Overexpressing Breast Cancer After Transtuzumab Failure in the Neoadjuvant or Adjuvant Setting
- Massarweh, Suleiman (PI)